Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: fut, so you think that the conversion and release to the market..tc

Apr 05, 2007 11:34AM
"At May 31, 2006, the Company had warrants outstanding to purchase 53,349,220 common shares"
From the 10k. Latest reported number on warrants outstanding was what, around 29m. I think you better re-check your calculation of 50m shares dumped for warrant conversion.
Share
New Message
Please login to post a reply